Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- January 2016
- DOI:
- Bibcode:
- 2016PLoSO..1145409W